Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

China's National Medical Products Administration Approves New Oncology Drug Focusing on Targeted Therapy

Sunday, August 31, 2025

The National Medical Products Administration NMPA has granted approval for a novel oncology drug targeting specific molecular pathways a significant advancement in targeted cancer therapy

IQVIA and Flagship Pioneering form collaboration to support growth of life sciences companies

Friday, August 29, 2025

IQVIA has announced a strategic collaboration with Flagship Pioneering The partnership aims to accelerate the growth of Flagships network of biopharma companies by using IQVIAs expertise and resources These include access to extensive data advanced a...

D3 Bio Receives FDA Breakthrough and Orphan Drug Designations for KRAS G12C Inhibitor

Friday, August 29, 2025

D Bio has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to its investigational drug DS for the treatment of adults with KRAS GCmutated nonsmall cell lung cancer NSCLC

Travere Therapeutics Receives Approval for Updated REMS Labelling of FILSPARI® in IgA Nephropathy

Thursday, August 28, 2025

Travere Therapeutics has announced that the US Food and Drug Administration FDA has approved updated Risk Evaluation and Mitigation Strategy REMS labelling for FILSPARI sparsentan the only dual endothelin

Pfizer and BioNTech’s COMIRNATY® COVID-19 Vaccine Receives Approval for Older Adults and High-Risk Groups

Thursday, August 28, 2025

Pfizer and BioNTech have received approval from the US Food and Drug Administration FDA for their LPadapted monovalent COVID vaccine COMIRNATY LP

Sandoz Launches Rivaroxaban in Germany, Broadening Affordable Antithrombotic Access

Thursday, August 28, 2025

Sandoz has introduced its generic version of rivaroxaban in Germany making available new strengths of mg mg and mg under the brand Rivaroxaban A Pharma

Heidelberg Pharma’s Partner Telix Receives FDA Complete Response Letter for TLX250-CDx

Thursday, August 28, 2025

Heidelberg Pharma announced that its licensing partner Telix Pharmaceuticals has received a Complete Response Letter CRL from the US Food and Drug Administration FDA for its Biologics License Application BLA for TLXCDx